The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side ...
Flow Neuroscience's FL-100 headset, using transcranial direct current stimulation for at-home depression treatment, has FDA approval for major depressive disorder. Available in the US by late 2026 ...
WASHINGTON — The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can ...
The headset uses transcranial direct current stimulation, where electrical energy is directed into the head from the outside. (Representative Image) The US Food and Drug Administration approved Flow ...
Hosted on MSN
US FDA approves first at-home device for depression
Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback